H. Chen et al. / Tetrahedron Letters 53 (2012) 7147–7149
7149
6
.
.
(a) Milligan, G. L.; Mossman, C. J.; Aubé, J. J. Am. Chem. Soc. 1995, 117, 10449–
1459; (b) Lee, H. L.; Aubé, J. Tetrahedron 2007, 63, 9007–9015.
(a) Li, X.-L.; Zhu, Z.-G.; Duan, K.-F.; Chen, H.; Li, Z.-W.; Li, Z.; Zhang, P.-Z.
Tetrahedron 2009, 65, 2322–2328; (b) Li, X.-L.; Qin, Z.-B.; Yang, T.-Y.; Zhang, H.-
Z.; Wei, S.-N.; Li, C.-X.; Chen, H.; Meng, M. Bioorg. Med. Chem. Lett. 2012, 22,
168 °C2b), 1H NMR (600 MHz, MeOD) d
(t, J = 3.6 Hz, 1H, CH), 3.80 (t, J = 4.8 Hz, 1H, CH), 3.77 (dd, J = 10.8 Hz, 4.2 Hz,
H
(ppm): 4.26 (d, J = 3.6 Hz, 1H, CH), 3.96
1
13
7
1H, CH), 3.62 (dd, J = 10.8 Hz, 7.2 Hz, 1H, CH
NMR (150 MHz, MeOD) d (ppm): 174.2, 74.3, 69.8, 69.6, 64.0, 60.5; HRESIMS:
calcd for C 11NO Na ([M+Na] ) 200.0535, found: 200.0541. (3S,4S,5R,6S)-
3,4,5-Trihydroxy-6-(hydroxymethyl) piperidin-2-one (2b): White solid, yield 67%,
2
), 3.31–3.33 (m, 1H, CH
2
);
C
C
+
6
H
5
2
712–2716.
3
2
+27.1 (c 1.0, MeOH); 1H NMR (600 MHz, MeOD) d
H
8
.
(a) Suhara, Y.; Kittaka, A.; Ono, K.; Kurihara, M.; Fujishima, T.; Yoshida, A.;
Takayama, H. Bioorg. Med. Chem. Lett. 2002, 12, 3533–3536; (b) Isabel García-
Moreno, M.; Mellet, C. O.; García-Fernández, J. M. Eur. J. Org. Chem. 2004, 1803–
mp 172–173 °C; ½
aꢀ
D
(ppm): 4.30 (d, J = 3.0 Hz, 1H, CH), 4.14 (t, J = 3.6 Hz, 1H, CH), 4.07–4.08 (m, 1H,
13
CH), 3.73–3.77 (m, 2H, CH, CH
NMR (150 MHz, MeOD) d (ppm): 173.9, 70.9, 67.5, 67.1, 61.4, 54.3; HRESIMS:
calcd for C 11NO Na ([M+Na] ) 200.0535, found: 200.0523. (3S,4S,5R)-3,4,5-
Trihydroxy piperidin-2-one (2c): White solid, yield 61%, mp 196–198 °C; ½
2
), 3.69 (dd, J = 10.2 Hz, 4.2 Hz, 1H, CH
2
);
C
1
819; (c) Timmer, M. S. M.; Risseeuw, M. D. P.; Verdoes, M.; Filippov, D. V.;
C
+
Plaisier, J. R.; van der Marel, G. A.; Overkleeft, H. S.; van Boom, J. H. Tetrahedron:
Asymmetry 2005, 16, 177–185; (d) Cosme, G. F.; Raimundo, F.; Concepcion, C.
G.; Elisa, I. L.; Concepcion, R. F.; Ernesto, S. J. Org. Chem. 2001, 66, 1861–1866.
(a) Xu, J.-X. Chemistry 2007, 19, 700–712 (in Chinese); (b) Kappe, C. O. Angew.
Chem., Int. Ed. 2004, 43, 6250–6284.
6
H
5
3
2
a
ꢀ
D
1
ꢁ18.6 (c 1.0, MeOH); H NMR (600 MHz, MeOD) d
H
(ppm): 4.32 (d, J = 3.0 Hz,
9
.
1H, CH), 4.09 (t, J = 4.2 Hz, 1H, CH), 4.03 (t, J = 4.2 Hz, 1H, CH), 3.66 (dd,
13
2 2
J = 13.2 Hz, 3.6 Hz, 1H, CH ), 3.16 (dd, J = 13.2 Hz, 2.4 Hz, 1H, CH ); C NMR
1
0. General procedure for the synthesis of d-glyconolactams 2: Azidosugar
1.0 mmol) was dissolved in 3 mL 80% CF COOH and was stirred in sealed
tube at 50 °C under microwave irradiation in CEM Discover S-Class
1
(150 MHz, MeOD) d (ppm): 173.6, 74.9, 71.0, 67.3, 44.8; HRESIMS: calcd for
C
+
(
3
C
5
H
9
NO
piperidin-2-one (2d): White solid, yield 63%, mp 147–148 °C; ½
MeOH); 1H NMR (600 MHz, D
O) d (ppm): 4.11–4.16 (m, 3H, 3CH), 3.34 (dd,
J = 12 Hz, 6.6 Hz, 1H, CH ), 3.22 (t, J = 10.2 Hz, 1H, CH
O) d (ppm): 173.3, 70.9, 68.2, 64.7, 42.5; HRESIMS: calcd for C
4
Na ([M+Na] ) 170.0429, found: 170.0433. (3R,4R,5R)-3,4,5-trihydroxy
32
a
aꢀ
+35.3 (c 1.0,
D
Synthesizer for 5 min. After the reaction complete, the solvent was
evaporated under reduced pressure to get a crude product that was purified
using flash column chromatography (ethyl acetate–methanol V/V = 7:1–3:1) to
get d-glyconolactams 2. (3S,4S,5R,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)
piperidin-2-one (2a): White solid, yield 69%; mp 164–165 °C (lit. mp 163–
2
H
13
2
2
); C NMR (150 MHz,
NO Na
D
2
C
5
H
9
4
+
([M+Na] )170.0429, found:170.0421.
11. Szostak, M.; Yao, L.; Aube, J. Org. Lett. 2009, 11, 4386–4389.